全文获取类型
收费全文 | 409444篇 |
免费 | 26153篇 |
国内免费 | 1452篇 |
专业分类
耳鼻咽喉 | 2718篇 |
儿科学 | 12975篇 |
妇产科学 | 14991篇 |
基础医学 | 42064篇 |
口腔科学 | 9953篇 |
临床医学 | 47166篇 |
内科学 | 82273篇 |
皮肤病学 | 6137篇 |
神经病学 | 35812篇 |
特种医学 | 17367篇 |
外国民族医学 | 2篇 |
外科学 | 55351篇 |
综合类 | 5808篇 |
现状与发展 | 17篇 |
一般理论 | 161篇 |
预防医学 | 51742篇 |
眼科学 | 4926篇 |
药学 | 19896篇 |
27篇 | |
中国医学 | 1159篇 |
肿瘤学 | 26504篇 |
出版年
2024年 | 597篇 |
2023年 | 18872篇 |
2022年 | 26984篇 |
2021年 | 29292篇 |
2020年 | 30115篇 |
2019年 | 19662篇 |
2018年 | 20163篇 |
2017年 | 20904篇 |
2016年 | 19705篇 |
2015年 | 17939篇 |
2014年 | 32688篇 |
2013年 | 26902篇 |
2012年 | 16601篇 |
2011年 | 14899篇 |
2010年 | 20131篇 |
2009年 | 18660篇 |
2008年 | 10535篇 |
2007年 | 10254篇 |
2006年 | 8500篇 |
2005年 | 7006篇 |
2004年 | 5955篇 |
2003年 | 5800篇 |
2002年 | 5911篇 |
2001年 | 5473篇 |
2000年 | 4691篇 |
1999年 | 4943篇 |
1998年 | 3622篇 |
1997年 | 2952篇 |
1996年 | 3056篇 |
1995年 | 2572篇 |
1994年 | 1953篇 |
1993年 | 1546篇 |
1992年 | 1924篇 |
1991年 | 1792篇 |
1990年 | 1861篇 |
1989年 | 1485篇 |
1988年 | 1734篇 |
1987年 | 1308篇 |
1986年 | 1054篇 |
1985年 | 743篇 |
1984年 | 942篇 |
1983年 | 733篇 |
1982年 | 807篇 |
1981年 | 719篇 |
1980年 | 592篇 |
1979年 | 370篇 |
1978年 | 398篇 |
1977年 | 331篇 |
1976年 | 268篇 |
1975年 | 164篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
《Vaccine》2022,40(52):7526-7537
BackgroundInjection-related pain and fear are common adverse reactions in children undergoing vaccination and influence vaccine acceptance. Despite the large body of literature on sources of vaccine non-compliance, there is no estimate of the prevalence of pain and fear as contributing factors. The objective was to estimate the prevalence of injection pain or fear of needles as barriers to childhood (i.e., 0–18 years) vaccination.MethodsFour databases were searched from inception for relevant English and French articles until August 2021. In addition, the references of recent systematic reviews and all articles included in the review were hand searched. Article screening and data extractions were performed in duplicate. Studies were included if they reported on injection-related pain or fear of needles in children (0–18 years) using a checklist/closed-ended question(s). Results were stratified by respondent (parents or children), type of pediatric population (general or under-vaccinated), and relative importance of barrier (pain or needle fear as primary reason or any reason for under-vaccination). Prevalence rates of pain or needle fear were combined using a random effects model. Quality of included studies was assessed using the Joanna Briggs Institute critical appraisal checklist for prevalence data. Quality across studies was assessed using GRADE.ResultsThere were 26 studies with 45 prevalence estimates published between 1995 and 2021. For parent reports (of children) and children self-reported reasons for non-compliance, prevalence rates of pain or needle fear ranged from 5 to 13% in a general population and 8 to 28% in an under-vaccinated population, with a substantial variation in the prevalence estimates. There was no difference between category of respondent or relative importance on pain or needle fear prevalence rate. A regression model demonstrated an overall prevalence rate of pain or needle fear as an obstacle to vaccination of 8% in the general population and 18.3% in the under-vaccinated population. All evidence was very low in quality.ConclusionThis is the first review to systematically quantify the prevalence and therefore, importance, of pain and needle fear as obstacles to vaccination in children around the world. Pain from injection or fear of needles were demonstrated to be sufficiently prevalent as barriers to vaccination in children to warrant attention. Addressing pain and fear has the potential to significantly improve vaccination acceptance. 相似文献
992.
993.
994.
《Digestive and liver disease》2022,54(8):1038-1043
BackgroundEvidence is accumulating that liver sinusoidal endothelial cells are involved in the pathogenesis of non-alcoholic fatty liver disease. Previous studies have suggested that the endothelial biomarker soluble E-selectin (sE-selectin) is to an important extent liver-derived.AimsTo study the relationship of intrahepatic lipid (IHL) content with sE-selectin at the population level.MethodsThis study was conducted in participants of The Maastricht Study (n = 1,634), a population-based cohort study enriched with patients with type 2 diabetes. We assessed the cross-sectional association between IHL content, quantified by MRI, and sE-selectin via multivariable regression with adjustment for age, sex, type 2 diabetes, educational level, BMI, Dutch Healthy Diet index, physical activity, and the Matsuda index.ResultsStandardized IHL content was associated with (log) sE-selectin (age-, sex- and type 2 diabetes-adjusted regression coefficient [B]: 0.048 [95%CI:0.038;0.058], p<0.001), even after full adjustment (B: 0.030 [0.019;0.042], p<0.001). Such an association was not observed for soluble vascular cell adhesion molecule 1 (sVCAM-1) levels.ConclusionIHL content is an independent determinant of sE-selectin at the population level. These findings support further studies to unravel the involvement of liver sinusoidal endothelial cells in the different stages of non-alcoholic fatty liver disease and the specific role of E-selectin herein. 相似文献
995.
Bacterial keratitis continues to be one of the leading causes of corneal blindness in the developed as well as the developing world, despite swift progress since the dawn of the “anti-biotic era”. Although, we have expeditiously developed our understanding about the different causative organisms and associated pathology leading to keratitis, extensive gaps in knowledge continue to dampen the efforts required for early and accurate diagnosis, and management in these patients, resulting in poor clinical outcomes. The ability of the causative bacteria to subdue the therapeutic challenge stems from their large genome encoding complex regulatory networks, variety of unique virulence factors, and rapid secretion of tissue damaging proteases and toxins.In this review article, we provide an overview of the established diagnostic techniques and therapeutics for keratitis caused by various bacteria. We extensively report the recent in-roads through novel tools for accurately diagnosing mono- and poly-bacterial corneal infections. Furthermore, we outline the recent progress by our groups and others in understanding the sub-cellular genomic changes that lead to antibiotic resistance in these organisms. Finally, we discuss in detail, the novel therapies and drug delivery systems in development for the efficacious management of bacterial keratitis. 相似文献
996.
《Clinical Lymphoma, Myeloma & Leukemia》2022,22(8):608-617
BackgroundConsiderable progress has been made in therapeutic options for multiple myeloma (MM). Understanding the current landscape of MM treatment options and associated outcomes in the real world is important in providing key insights into clinical and knowledge gaps which could be targeted for further optimization.MethodsThe Canadian Myeloma Research Group Database (CMRG-DB) is a prospectively maintained disease-specific database with >7000 patients. The objective of this study was to describe the trends in the treatment landscape and outcomes including early mortality, time to next treatment, and overall survival (OS) in each line of treatment stratified by autologous stem cell transplant (ASCT) receipt among newly-diagnosed MM patients in Canada between 2007 and 2018.ResultsA total of 5154 patients were identified among which 3030 patients (58.8%) received an upfront ASCT and 2124 (41.2%) did not. At diagnosis, the median age was 64 years and 58.6% were males. Bortezomib and lenalidomide were most frequently used (>50%) in first and second-line treatment respectively among both the ASCT and non-ASCT cohort. The median OS was 122.0 months (95% Cl 115.0-135.0 months) and 54.3 months (95% CI 50.8-58.8 months) for the ASCT and non-ASCT cohort respectively with an incremental decrease in OS in each subsequent line of treatment.ConclusionWe present the largest study to date in the Canadian landscape showing the characteristics, therapy usage, and outcomes among MM patients. This information will be critical in benchmarking current outcomes and provide key insight into areas of unmet needs and gaps for improvement of MM patients nationally. 相似文献
997.
998.
999.
1000.